全球細胞分級分離市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計細胞分級市場將從 2025 年的 3.065 億美元成長到 2034 年的 6.5802 億美元，2026 年至 2034 年的複合年成長率為 8.86%。

隨著生物醫學研究、免疫療法和診斷技術對細胞群體的精確高通量分離的需求日益成長，細胞分離市場正進入高速成長階段。未來的平台將整合微流體技術、人工智慧驅動的影像識別和自動化技術，以實現研究和臨床應用中的高純度、高活性和高通量分離。利用聲學、介電和光學操控的新型無標定分離技術將提高效率並減少對樣品的影響。

高速、多參數螢光活化細胞分選 (FACS) 系統憑藉其增強的光學系統、高速雷射掃描和即時數據分析功能，支援複雜的實驗流程。與生物資訊流程和雲端分析的整合，可促進下游分子譜分析、單細胞定序和預測建模。實驗室自動化和機器人樣品處理減少了人工干預，提高了實驗的可重複性。

未來成長將主要由個人化醫療、幹細胞療法和先進免疫療法的拓展所驅動。透過結合創新分選技術、人工智慧輔助分析和自動化，細胞分選市場將在加速研發、治療方法開發和精準醫療方面發揮核心作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球細胞分級市場：依產品分類

• 市場分析、洞察與預測
• 細胞分選儀
• 試劑和耗材
• 服務

第5章 全球細胞分級市場：依技術分類

• 市場分析、洞察與預測
• 基於螢光的液滴分離
• 細胞的磁激活
• MEMS－微流體技術

第6章 全球細胞分級市場：依應用分類

• 市場分析、洞察與預測
• 出於研究目的
• 臨床應用

第7章：全球細胞分離市場：依最終用途分類

• 市場分析、洞察與預測
• 研究機構
• 醫學院和學術機構
• 製藥和生物技術公司
• 醫院和臨床檢查室

第8章 全球細胞分級市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • BD
  • Bio-Rad Laboratories Inc
  • Danaher Corporation
  • Sony Group Corporation
  • Miltenyi Biotec
  • On-Chip Biotechnologies Co. Ltd
  • Cytonome/ST LLC
  • Union Biometrica Inc
  • Thermo Fisher Scientific Inc
  • UFluidix

The Cell Sorting Market size is expected to reach USD 658.02 Million in 2034 from USD 306.50 Million (2025) growing at a CAGR of 8.86% during 2026-2034.

The cell sorting market is entering a high-growth phase as biomedical research, immunotherapy, and diagnostics increasingly rely on precise, high-throughput isolation of cell populations. Future platforms will integrate microfluidic technologies, AI-driven image recognition, and automation to achieve high purity, viability, and throughput for research and clinical applications. Emerging label-free sorting techniques using acoustic, dielectric, and optical manipulation will enhance efficiency and reduce sample perturbation.

High-speed, multi-parameter fluorescence-activated cell sorting (FACS) systems will benefit from enhanced optics, faster laser scanning, and real-time data analytics to support complex experimental workflows. Integration with bioinformatics pipelines and cloud-based analytics will facilitate downstream molecular profiling, single-cell sequencing, and predictive modeling. Lab automation and robotic sample handling will reduce manual intervention and enhance reproducibility.

Future growth will be driven by the expansion of personalized medicine, stem cell therapies, and advanced immunotherapies. By combining innovative sorting technologies, AI-assisted analytics, and automation, the cell sorting market will play a central role in accelerating research, therapeutic development, and precision healthcare.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Cell Sorters
• Reagents and Consumables
• Services

By Technology

• Fluorescence-based Droplet Cell Sorting
• Magnetic-activated Cell Sorting
• MEMS - Microfluidics

By Application

• Research Applications
• Clinical Applications

By End Use

• Research Institutions
• Medical Schools and Academic Institutions
• Pharmaceutical and Biotechnology Companies
• Hospitals and Clinical Testing Laboratories

COMPANIES PROFILED

• BD, BioRad Laboratories Inc, Danaher Corporation, Sony Group Corporation, Miltenyi Biotec, Onchip Biotechnologies Co Ltd, CytonomeST LLC, Union Biometrica Inc, Thermo Fisher Scientific Inc, uFluidix
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CELL SORTING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Cell Sorters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagents and Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CELL SORTING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Fluorescence-based Droplet Cell Sorting Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Magnetic-activated Cell Sorting Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. MEMS - Microfluidics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CELL SORTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Research Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Clinical Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CELL SORTING MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Research Institutions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Medical Schools and Academic Institutions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Hospitals and Clinical Testing Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CELL SORTING MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Technology
  • 8.2.3 By Application
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Technology
  • 8.3.3 By Application
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Technology
  • 8.4.3 By Application
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Technology
  • 8.5.3 By Application
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Technology
  • 8.6.3 By Application
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL CELL SORTING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 BD
  • 10.2.2 Bio-Rad Laboratories Inc
  • 10.2.3 Danaher Corporation
  • 10.2.4 Sony Group Corporation
  • 10.2.5 Miltenyi Biotec
  • 10.2.6 On-Chip Biotechnologies Co. Ltd
  • 10.2.7 Cytonome/ST LLC
  • 10.2.8 Union Biometrica Inc
  • 10.2.9 Thermo Fisher Scientific Inc
  • 10.2.10 UFluidix